Ubidecarenone
泛癸利酮
Report date: 2026/05/20 20:02:01
NME
Base Information
Drug NameUbidecarenone
Drug Alias Name +[18]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[23]
Global Approved Indications +[4]
Approved Indications in China
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesNetherlands Heart InstituteEisai LtdFayoum University +[9]
Inactive CompaniesWeill Medical College of Cornell UniversityAdventHealth Translational Research InstituteLahey Clinic Inc +[11]
Active Indications +[12]
Inactive Indications +[11]